Drug Profile
Research programme: selective androgen receptor modulators - Karo Pharma
Alternative Names: SARMs - Karo Pharma/RadiusLatest Information Update: 21 Dec 2016
Price :
$50
*
At a glance
- Originator Karo Bio
- Class
- Mechanism of Action Selective androgen receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Osteoporosis; Sarcopenia
Most Recent Events
- 28 Feb 2008 Discontinued - Preclinical for Osteoporosis in USA (PO)
- 28 Feb 2008 Discontinued - Preclinical for Sarcopenia in USA (PO)
- 12 Sep 2006 Preclinical trials in Osteoporosis in USA (PO)